Porosome Therapeutics, Inc.
Home
ABOUT US
PLATFORM
PIPELINE
TEAM
NEWS
Contact
Porosome Therapeutics, Inc.
Home
ABOUT US
PLATFORM
PIPELINE
TEAM
NEWS
Contact
Home
NEWS
Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint
Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint
Reprogramming the cells secretory machinery: A cystic fibrosis rescue | bioRxiv
Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)
From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies
From the CEO's DESK (2026)